Zedge to Report Fiscal Third Quarter 2021 Results
NEW YORK, NY / ACCESSWIRE / May 27, 2021 / Zedge, Inc., (NYSE American:ZDGE) will report…
NEW YORK, NY / ACCESSWIRE / May 27, 2021 / Zedge, Inc., (NYSE American:ZDGE) will report…
SUDBURY, ON / ACCESSWIRE / May 27, 2021 / Northern Superior Resources (“Northern Superior” or…
RecycLiCo™ Sample Outperformed Commercial Grade Cathode Precursor Purity SURREY, BC / ACCESSWIRE / May 27,…
VANCOUVER, BC / ACCESSWIRE / May 27, 2021 / NeutriSci International Inc. (“NeutriSci” or the…
VANCOUVER, BC / ACCESSWIRE / May 27, 2021 / Gold Mountain Mining Corp. (“Gold Mountain”…
SHERMAN OAKS, CA / ACCESSWIRE / May 27, 2021 / Petroteq Energy Inc. (“Petroteq” or…
LONDON, UK / ACCESSWIRE / May 27, 2021 / Gamesys Group plc (LSE:GYS) (the “Company“), announces…
LONDON, UK / ACCESSWIRE / May 27, 2021 / Gamesys Group plc (LSE:GYS) (the “Company“), announces…
UKCloud strengthens its commitment to supporting Britain’s technology led economic recovery London – 27th May…
Growth strategy, customer expectations and competitive pressures are key drivers of investments in real-time data…
Repeated immunization with AFFITOPE® peptide active immunotherapy candidates AT04A and AT06A is safe, well-tolerated and…
BASEL, Switzerland and MANNHEIM, Germany, May 27, 2021 (GLOBE NEWSWIRE) — VAXIMM AG, a Swiss/German…
Oslo, 27 May 2021. PCI Biotech Holding ASA (“PCI Biotech” or the “Company”) issue this…
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945…
COPENHAGEN, Denmark, May 27, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today…
COPENHAGEN, Denmark, May 27, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today…
Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate Two-stage…
COPENHAGEN, Denmark, May 27 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has entered…
EMPATHY global multi-center Phase 2 – 3 study, recruiting patients with COVID-19 infection, aiming to…
Pratteln, Switzerland, May 27, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces the invitation to its Annual…